• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无触须 HIV 蛋白酶:HIV-1 失活的一种可能途径。

Whiskers-less HIV-protease: a possible way for HIV-1 deactivation.

机构信息

Department of Biology, Faculty of Science, Shahid Chamran University, Ahvaz, Iran.

出版信息

J Biomed Sci. 2013 Sep 12;20(1):67. doi: 10.1186/1423-0127-20-67.

DOI:10.1186/1423-0127-20-67
PMID:24024748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3847613/
Abstract

BACKGROUND

Among viral enzymes, the human HIV-1 protease comprises the most interesting target for drug discovery. There are increasing efforts focused on designing more effective inhibitors for HIV-1 protease in order to prevent viral replication in AIDS patients. The frequent and continuous mutation of HIV-1 protease gene creates a formidable obstacle for enzyme inhibition which could not be overcome by the traditional single drug therapy. Nowadays, in vitro and in silico studies of protease inhibition constitute an advanced field in biological researches. In this article, we tried to simulate protease-substrate complexes in different states; a native state and states with whiskers deleted from one and two subunits. Molecular dynamic simulations were carried out in a cubic box filled with explicit water at 37°C and in 1atomsphere of pressure.

RESULTS

Our results showed that whisker truncation of protease subunits causes the dimer structure to decrease in compactness, disrupts substrate-binding site interactions and changes in flap status simultaneously.

CONCLUSIONS

Based on our findings we claim that whisker truncation even when applied to a single subunit, threats dimer association which probably leads to enzyme inactivation. We may postulate that inserting a gene to express truncated protease inside infected cells can interfere with protease dimerization. The resulted proteases would presumably have a combination of native and truncated subunits in their structures which exert no enzyme activities as evidenced by the present work. Our finding may create a new field of research in HIV gene therapy for protease inhibition, circumventing problems of drug resistance.

摘要

背景

在病毒酶中,人类 HIV-1 蛋白酶是药物发现最有趣的目标。为了防止艾滋病患者体内病毒复制,人们越来越关注设计更有效的 HIV-1 蛋白酶抑制剂。HIV-1 蛋白酶基因的频繁和持续突变给酶抑制带来了巨大的障碍,这是传统的单一药物治疗无法克服的。如今,蛋白酶抑制的体外和计算研究构成了生物研究的一个先进领域。在本文中,我们试图模拟不同状态下的蛋白酶-底物复合物;一个天然状态和从一个和两个亚基中删除须状结构的状态。分子动力学模拟在一个充满显式水的立方盒中进行,温度为 37°C,压力为 1 个大气压。

结果

我们的结果表明,蛋白酶亚基的须状结构截断导致二聚体结构的紧凑性降低,破坏了底物结合位点的相互作用,并同时改变了瓣状态。

结论

根据我们的发现,我们声称须状结构截断即使应用于单个亚基,也会威胁到二聚体的缔合,这可能导致酶失活。我们可以假设,在感染细胞中插入表达截断蛋白酶的基因可以干扰蛋白酶的二聚化。由此产生的蛋白酶可能在其结构中具有天然和截断亚基的组合,正如本工作所证明的那样,它们没有酶活性。我们的发现可能为 HIV 基因治疗中的蛋白酶抑制开辟一个新的研究领域,规避耐药性问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/1c43ee2392e2/1423-0127-20-67-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/c647a0fb0d9b/1423-0127-20-67-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/babae740d45a/1423-0127-20-67-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/050b3439c6c1/1423-0127-20-67-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/bae1885fcbfb/1423-0127-20-67-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/5ef3a7ab6904/1423-0127-20-67-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/1c43ee2392e2/1423-0127-20-67-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/c647a0fb0d9b/1423-0127-20-67-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/babae740d45a/1423-0127-20-67-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/050b3439c6c1/1423-0127-20-67-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/bae1885fcbfb/1423-0127-20-67-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/5ef3a7ab6904/1423-0127-20-67-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f27f/3847613/1c43ee2392e2/1423-0127-20-67-6.jpg

相似文献

1
Whiskers-less HIV-protease: a possible way for HIV-1 deactivation.无触须 HIV 蛋白酶:HIV-1 失活的一种可能途径。
J Biomed Sci. 2013 Sep 12;20(1):67. doi: 10.1186/1423-0127-20-67.
2
Protein promiscuity: drug resistance and native functions--HIV-1 case.蛋白质的多特异性:耐药性与天然功能——以HIV-1为例
J Biomol Struct Dyn. 2005 Jun;22(6):615-24. doi: 10.1080/07391102.2005.10531228.
3
How Mutations Can Resist Drug Binding yet Keep HIV-1 Protease Functional.突变如何在抵抗药物结合的同时保持HIV-1蛋白酶的功能。
Biochemistry. 2017 Jun 13;56(23):2907-2920. doi: 10.1021/acs.biochem.7b00139. Epub 2017 Jun 1.
4
Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease.关于HIV-1蛋白酶非活性位点突变V77I导致奈非那韦耐药性分子机制的结构研究
BMC Bioinformatics. 2015;16 Suppl 19(Suppl 19):S10. doi: 10.1186/1471-2105-16-S19-S10. Epub 2015 Dec 16.
5
An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface.通过靶向亚基界面抑制二聚体HIV-1蛋白酶多药耐药突变体的另一种策略。
Biochem Soc Trans. 2007 Jun;35(Pt 3):551-4. doi: 10.1042/BST0350551.
6
A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.一项比较野生型与多重耐药性HIV蛋白酶的分子动力学研究:瓣片和天冬氨酸25腔尺寸的差异。
Proteins. 2007 Nov 15;69(3):551-65. doi: 10.1002/prot.21535.
7
Folded monomer of HIV-1 protease.HIV-1蛋白酶的折叠单体
J Biol Chem. 2001 Dec 28;276(52):49110-6. doi: 10.1074/jbc.M108136200. Epub 2001 Oct 11.
8
Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach.野生型和突变型HIV蛋白酶的小分子二聚化抑制剂:一种聚焦文库方法
J Am Chem Soc. 2004 Aug 18;126(32):9886-7. doi: 10.1021/ja048139n.
9
Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir.耐药性突变对HIV-1蛋白酶动力学特性的影响以及安普那韦和达芦那韦的抑制作用。
Sci Rep. 2015 May 27;5:10517. doi: 10.1038/srep10517.
10
Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes.HIV-1蛋白酶耐药突变体的结构影响:突变蛋白酶/底物类似物复合物的高分辨率晶体结构
Proteins. 2001 Jun 1;43(4):455-64. doi: 10.1002/prot.1057.

引用本文的文献

1
Inhibition of HIV-1 Protease by (L.).(拉汉属名未明确,无法准确翻译属名部分)对HIV-1蛋白酶的抑制作用 。
Evid Based Complement Alternat Med. 2020 Jun 7;2020:9648056. doi: 10.1155/2020/9648056. eCollection 2020.
2
Resistance mechanism of human immunodeficiency virus type-1 protease to inhibitors: A molecular dynamic approach.1型人类免疫缺陷病毒蛋白酶对抑制剂的耐药机制:一种分子动力学方法。
Mol Biol Res Commun. 2014 Dec;3(4):253-267.
3
Comparison of Newly Assembled Full Length HIV-1 Integrase With Prototype Foamy Virus Integrase: Structure-Function Prospective.

本文引用的文献

1
Molecular Dynamics Simulations of HIV-1 Protease Suggest Different Mechanisms Contributing to Drug Resistance.HIV-1 蛋白酶的分子动力学模拟提示了导致耐药性的不同机制。
J Chem Theory Comput. 2005 Mar;1(2):315-24. doi: 10.1021/ct049869o.
2
Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease.观察HIV-1蛋白酶氨基末端自加工过程中的瞬时事件。
Nature. 2008 Oct 2;455(7213):693-6. doi: 10.1038/nature07342.
3
Differential inhibition of cytosolic PEPCK by substrate analogues. Kinetic and structural characterization of inhibitor recognition.
新组装的全长HIV-1整合酶与原型泡沫病毒整合酶的比较:结构-功能展望
Jundishapur J Microbiol. 2016 Feb 15;9(5):e29773. doi: 10.5812/jjm.29773. eCollection 2016 May.
4
Mechanism of preferential packaging of negative sense genomic RNA by viral nucleoproteins in Crimean-Congo hemorrhagic Fever virus.克里米亚-刚果出血热病毒中病毒核蛋白对负义基因组RNA的优先包装机制。
Protein J. 2015 Apr;34(2):91-102. doi: 10.1007/s10930-015-9601-6.
底物类似物对胞质磷酸烯醇式丙酮酸羧激酶的差异抑制作用。抑制剂识别的动力学和结构特征
Biochemistry. 2008 Feb 19;47(7):2099-109. doi: 10.1021/bi7020662. Epub 2008 Jan 16.
4
HIV-1 protease: structure, dynamics, and inhibition.HIV-1蛋白酶:结构、动力学与抑制作用
Adv Pharmacol. 2007;55:261-98. doi: 10.1016/S1054-3589(07)55008-8.
5
Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor.旨在表征HIV-1蛋白酶单体及其前体的突变和结构研究。
J Biol Chem. 2007 Jun 8;282(23):17190-9. doi: 10.1074/jbc.M701304200. Epub 2007 Apr 4.
6
Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.利用界面肽破坏HIV-1蛋白酶二聚体:结合[2-(13)C]-色氨酸选择性标记的核磁共振光谱结构研究
Biopolymers. 2007;88(2):164-73. doi: 10.1002/bip.20685.
7
Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114.HIV-1蛋白酶突变体的超高分辨率晶体结构揭示了临床抑制剂TMC114的两个结合位点。
J Mol Biol. 2006 Oct 13;363(1):161-73. doi: 10.1016/j.jmb.2006.08.007. Epub 2006 Aug 4.
8
HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state.在将一种抑制剂手动置于开放状态后进行的模拟中,HIV-1蛋白酶的瓣片会自发地闭合至正确结构。
J Am Chem Soc. 2006 Mar 8;128(9):2812-3. doi: 10.1021/ja058211x.
9
Flap opening mechanism of HIV-1 protease.HIV-1蛋白酶的瓣打开机制。
J Mol Graph Model. 2006 May;24(6):465-74. doi: 10.1016/j.jmgm.2005.08.008. Epub 2005 Sep 26.
10
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.新一代HIV-1蛋白酶抑制剂TMC114的发现与筛选。
J Med Chem. 2005 Mar 24;48(6):1813-22. doi: 10.1021/jm049560p.